The Recurrence of Colon Cancer

For those of you who have friends or family members who fought colon cancer, or were victims themselves, know how terrible this disease can be. After surviving the disease, no one wants to relive his past, or live on the edge of knowing that, if they can have them again, or it can succumb to its effects years later. Unfortunately, this is not always the case as a colorectal cancer was noted as having a high rate of recurrence. Specifically, it is stated that approximately 20% of patients with untreated colorectal cancer shows signs of repeated within five years.

Colon cancer is a disease that takes over the walls of the colon with abnormal growths called tumors. Affect the secretion of the part of the digestive process, victims are still trying to reduce the spread of cancer that affects other vital organs in the body such as the liver. In particular, the functions of the colon include absorbs minerals and water storage, creating the expulsion of feces, storing bacteria to help digestion and thus prevents the growth and circulation of harmful bacteria and maintain the proper pH for the reaction.

In general, other researchers have noted that the repetition rate of colorectal cancer varies between 4% and 55%. However, technology came to the rescue once again. Scientists have devised a genetic test, in which the return of a patient with colorectal cancer is predicted. Ideally, it scans the patient's genes in the early stages of the first cancer diagnosis to the condition in which the chances the disease will return after treatment.

Generally, this is a great success, and can do a lot in the process of treatment because of information obtained from the test can help the doctor determine whether chemotherapy is a good choice after surgery due to the fact that it will eventually reappear. In fact, it can help a doctor decide whether surgery should be the only method of treatment used, or whether chemotherapy and radiation therapy should also be conducted, which is a little more intense.

I hope that in 2010, this test can be run commercially, as the alleged genocide by health science company founded in order to improve the quality of cancer treatment in patients with the research, development and commercialization of medical laboratory services. As Dr. Leonard Saltz puts it simply "test clearly tells people that they are more likely to be found in the group at high risk or low risk of recurrence." All in all, it provides patients with the overall comfort of deciding whether or not to do chemotherapy, which is another piece of information that can lead to disputes between doctors and patients about their status, and the best option moving forward.